Labeling Type
PLASMA DERIVATIVE
Status
Approved
Full Title
These highlights do not include all the information needed to use HYQVIA safely and effectively. See full prescribing information for HYQVIA. HYQVIA [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 2014
United States
Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.
